Assessing adherence factors in patients under topical treatment: Development of the Topical Therapy Adherence Questionnaire (TTAQ)

Archives of Dermatological Research

Volumn 306, Issue 3, 2014, Pages 287-297

  Zschocke, Ina ^a   Mrowietz, Ulrich ^b   Lotzin, Annett ^a   Karakasili, Eleni ^a   Reich, Kristian ^c  

^a SCIderm GmbH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c DERMATOLOGIKUM HAMBURG   (Germany)

Author keywords

Adherence; Compliance; Psoriasis; Questionnaire; Topical therapy; TTAQ

Indexed keywords

ANTIPSORIASIS AGENT;

ARTICLE; HUMAN; PATIENT COMPLIANCE; PATIENT PREFERENCE QUESTIONNAIRE; PRIORITY JOURNAL; PSORIASIS; PSYCHOMETRY; QUESTIONNAIRE; RISK FACTOR; SYSTEMATIC REVIEW; TOPICAL THERAPY ADHERENCE QUESTIONNAIRE; TOPICAL TREATMENT;

ADMINISTRATION, CUTANEOUS; COMPREHENSION; DERMATOLOGIC AGENTS; FEASIBILITY STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; PATIENT PREFERENCE; PSORIASIS; PSYCHOMETRICS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84898844282     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1446-x     Document Type: Article

References (46)

1. Ashcroft DM, Li Wan PA, Williams HC, Griffiths CE (1998) Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 23:391-398
2. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:12
3. Augustin M, Dieterle W, Zschocke I, Brill C, Trefzer D, Peschen M, Schopf E, Vanscheidt W (1997) Development and validation of a disease-specific questionnaire on the quality of life of patients with chronic venous insufficiency. Vasa 26:291-301
4. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA (2011) Adherence in the treatment of psoriasis: a systematic review. Dermatology 222:363-374
5. Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I (2004) Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 14:107-113
6. Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schafer I, Reusch M, Mielke V, Rustenbach SJ (2009) The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 301:561-571
7. Augustin M, Wenninger K, Amon U, Schroth MJ, Kuster W, Chren M, Kupfer J, Gieler U (2004) German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 209:14-20
8. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D (2009) Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. Br J Psychiatry 195:170-177
9. Bewley A, Page B (2011) Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 25:9-14
10. Brawley LR, Culos-Reed SN (2000) Studying adherence to therapeutic regimens: overview, theories, recommendations. Control Clin Trials 21:156S-163S
11. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le MM, Richard-Lallemand MA, Ortonne JP (2010) What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):17-22
12. Brown KK, Wingfield ER, Kimball AB (2006) Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 55:607-613
13. Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clin Proc 86:304-314
14. Bryant LJ (2011) Medicines adherence-evidence for any intervention is disappointing. J Prim Health Care 3:240-243
15. Butler RJ, Davis TK, Johnson WG, Gardner HH (2011) Effects of nonadherence with prescription drugs among older adults. Am J Manag Care 17:153-160
16. Dimatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40:794-811
17. Dreno B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, Leutenegger E, Perez M (2010) Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 49:448-456
18. Epstein RS (2011) Medication adherence: hope for improvement? Mayo Clin Proc 86:268-270
19. Ersser SJ, Cowdell FC, Latter SM, Healy E (2010) Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol 163:1044-1049
20. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57:81-83
21. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC (2008) Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 59:1009-1016
22. Finlay AY, Kelly SE (1987) Psoriasis-an index of disability. Clin Exp Dermatol 12:8-11
23. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216
24. Flowers B, Wand M, Piltz-Seymour J, Berke SJ, Day D, Teague J, Smoot TM, Landry TA, Bergamini MV, Mallick S (2006) Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension. Clin Ther 28:1803-1811
25. Greenlaw SM, Yentzer BA, O'Neill JL, Balkrishnan R, Feldman SR (2010) Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol 16:253-258
26. Gupta G, Mallefet P, Kress DW, Sergeant A (2009) Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 161:221-227
27. Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R (2006) Adherence in dermatology: a review of the last 20 years. J Dermatol Treat 17:136-142
28. Hovstadius B, Petersson G (2011) Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study. BMC Health Serv Res 11:326 326
29. Ingersoll KS, Cohen J (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 31:213-224
30. Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE (2009) The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci 31:426-431
31. Kjellgren KI, Ring L, Lindblad A, Maroti M, Serup J (2004) To follow dermatological treatment regimens - patients' and providers' views. Acta Derm Venereol 84:445-450
32. Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Fleischer AB Jr, Balkrishnan R, Feldman SR (2007) Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 56:211-216
33. Lienert G (1969) Testaufbau und Testanalyse. Verlag Julius Beltz, Weinheim, Berlin, Basel
34. Martin LR, Williams SL, Haskard KB, Dimatteo MR (2005) The challenge of patient adherence. Ther Clin Risk Manag 1:189-199
35. Matsui D (2009) Strategies to measure and improve patient adherence in clinical trials. Pharm Med 23:289-297
36. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, Van AD (2003) Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 149:323-331
37. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HC (2006) Protocol of the COSMIN study: COnsensus-based standards for the selection of health measurement INstruments. BMC Med Res Methodol 6:2
38. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487-497
39. Picardi A, Pasquini P (2007) Toward a biopsychosocial approach to skin diseases. Adv Psychosom Med 28:109-126
40. Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337-343
41. Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, Puddu P, Braga M (2002) Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 138:337-342
42. Ribera M, Dauden E, Puig L, Briones VG, Herranz JM, Bordas X, Vanaclocha F (2011) Design and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study. Actas Dermo-Sifiliográficas 102:28-38
43. Sabaté E (2003) Adherence to long-term therapies - evidence for action, WHO. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf. Accessed 16 Jan 2014. WHO1-211
44. Schmidt J, Lamprecht F, Wittmann WW (1989) Satisfaction with inpatient management. Development of a questionnaire and initial validity studies. Psychother Psychosom Med Psychol 39:248-255
45. Storm A, Andersen SE, Benfeldt E, Serup J (2008) One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 59:27-33
46. Zschocke I, Seidenglanz K, Lange S, Schiffler A, Amon U (2000) Validation and clinical results of the FLQA-d, a quality of life questionnaire for patients with chronic skin diseases. Dermatol Psychosom 1:12-17